Sadly what you say is true, nothing will be said, nor should it be. Other companies would treat it no differently, however, I suspect some other companies would have moved more positively on the submission of the MAA. I can't say why we didn't, but suspect it revolves around the belief spurred by all the bashers, that management simply can't get the job done. When they're proven wrong, by gaining the UK approval, NWBO will fly.
There is little the company can do until the UK acts, but when they act this should become a very different company. Both LP and Dr. Liau should receive tremendous credit and be in high demand for speaking at the appropriate conferences, LP at Institutional and Brokerage conferences, Dr. Liau and others at technical conferences.
Today, I've got to guess that less than 1% of the investment community has heard of NWBO, after UK approval I suspect that number will go to 50% and growing routinely. Certainly not all who hear about NWBO will immediately, some investors simply won't buy a stock selling for less than $5 or $10 or more, they'll be in once we meet that criteria. If the news of approval breaks well, with major media coverage, it won't be long before we're looking at $5, $10, or more, and if the stock moves on emotion, no telling how high the peak may be.
Of course the bashing won't end, the same people saying we'll never get an approval will be saying, you'll never get it from the FDA. Time will tell, but with success in the UK, and acceptance of the EDEN unit, I feel quite certain the company will prove them just as wrong. It's been said that great leaders have done nothing at a time when nothing needed to be done. LP may be found to be such a leader, she didn't attempt to hype what was being done, she just got it done, once done, her efforts will speak for themselves.
Gary
